Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Hallbera GudmundsdottirJennifer A YonkusCornelius A ThielsSusanne G WarnerSean P ClearyMichael L KendrickMark J TrutyTravis E GrotzPublished in: Annals of surgical oncology (2023)
CRS/HIPEC in highly selected patients with PDAC and PM results in promising oncologic outcomes that are unlikely to be achieved with systemic chemotherapy alone. Further investigation is warranted and ongoing (NCT04858009).
Keyphrases
- locally advanced
- rectal cancer
- minimally invasive
- radical prostatectomy
- robot assisted
- particulate matter
- air pollution
- coronary artery bypass
- prostate cancer
- type diabetes
- squamous cell carcinoma
- radiation therapy
- heavy metals
- risk assessment
- skeletal muscle
- polycyclic aromatic hydrocarbons
- surgical site infection
- percutaneous coronary intervention
- water soluble